Editas Medicine (EDIT) Tops Q3 EPS by 5c

November 7, 2016 5:12 PM EST
Get Alerts EDIT Hot Sheet
Price: $18.76 --0%

Today's EPS Names:
More
Trade EDIT Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Editas Medicine (NASDAQ: EDIT) reported Q3 EPS of ($0.59), $0.05 better than the analyst estimate of ($0.64). Revenue for the quarter came in at $962 thousand versus the consensus estimate of $960 thousand.

For earnings history and earnings-related data on Editas Medicine (EDIT) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings

Related Entities

Earnings

Add Your Comment